Engineered human FcγRIIa fusion: A novel strategy to extend serum half‐life of therapeutic proteins-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineered human FcγRIIa fusion: A novel strategy to extend serum half‐life of therapeutic proteins

Published:2020-05-16 Issue:8 Volume:117 Page:2351-2361
ISSN:0006-3592
Container-title:Biotechnology and Bioengineering
language:en
Short-container-title:Biotechnology and Bioengineering

Author:

Jo Migyeong¹²,Ko Sanghwan¹²,Hwang Bora²,Min Sung‐Won³,Ha Ji Yeon¹,Lee Ji Chul³,Jang Se‐Eun⁴,Jung Sang Taek¹^ORCID

Affiliation:

1. Department of Biomedical SciencesGraduate School of Medicine, Korea University Seoul Republic of Korea

2. Department of Applied ChemistryKookmin University Seoul Republic of Korea

3. Life Science LaboratorySG Medical Seoul Republic of Korea

4. Department of Food and NutritionEulji University Seongnam‐si Gyeonggi‐do Republic of Korea

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.27374

Reference45 articles.

1. An investigation of oligopeptides linking domains in protein tertiary structures and possible candidates for general gene fusion

2. Engineering of recombinant human Fc receptor I by directed evolution

3. Short Communication: Renal Tubular Vacuolation in Animals Treated with Polyethylene-Glycol-Conjugated Proteins

4. Insulin analogues and their potential in the management of diabetes mellitus

5. Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An insight on lipid nanoparticles for therapeutic proteins delivery;Journal of Drug Delivery Science and Technology;2022-11

2. Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering;BioDrugs;2021-02-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3